Lignoceric acid-d47

目录号: PL09085
Lignoceric acid-d47 是 Lignoceric acid 的氘代物。Lignoceric acid (Tetracosanoic acid) 是一种 24 碳饱和 (24:0) 脂肪酸,在发育中的大脑中合成。Lignoceric acid 也是一种木质素生产的副产品。Lignoceric acid 可用于 Zellweger 脑-肝-肾综合征和肾上腺脑白质营养不良的研究。
CAS No. :68060-00-4
商品编号 规格 价格 会员价 是否有货 数量
PL09085-5mg 5mg 询价 询价
PL09085-10mg 10mg 询价 询价
PL09085-25mg 25mg 询价 询价
PL09085-50mg 50mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Lignoceric acid-d47
中文别名
二十四烷酸-d47;木焦油酸-D47;木焦油酸-D47氘代内标
英文名称
Lignoceric acid-d47
英文别名
Tetracosanoic-d47acid (9CI);TETRACOSANOIC-D47 ACID
Cas No.
68060-00-4
分子式
C24H48O2
分子量
415.93
包装储存
Please store the product under the recommended conditions in the Certificate of Analysis.
详情描述
Lignoceric acid-d47 是 Lignoceric acid 的氘代物。Lignoceric acid (Tetracosanoic acid) 是一种 24 碳饱和 (24:0) 脂肪酸,在发育中的大脑中合成。Lignoceric acid 也是一种木质素生产的副产品。Lignoceric acid 可用于 Zellweger 脑-肝-肾综合征和肾上腺脑白质营养不良的研究。
产品详情
Lignoceric acid-d47 是 Lignoceric acid 的氘代物。Lignoceric acid (Tetracosanoic acid) 是一种 24 碳饱和 (24:0) 脂肪酸,在发育中的大脑中合成。Lignoceric acid 也是一种木质素生产的副产品。Lignoceric acid 可用于 Zellweger 脑-肝-肾综合征和肾上腺脑白质营养不良的研究。
生物活性
Lignoceric acid-d 47 is the deuterium labeled Lignoceric acid. Lignoceric acid (Tetracosanoic acid) is a 24-carbon saturated (24:0) fatty acid, which is synthesized in the developing brain. Lignoceric acid is also a by-product of lignin production. Lignoceric acid can be used for Zellweger cerebro‐hepato‐renal syndrome and adrenoleukodystrophy research[1][2].
体外研究(In Vitro)
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[2]. Anna Petroni, et al. Thermogenic flux induced by lignoceric acid in peroxisomes isolated from HepG2 cells and from X-adrenoleukodystrophy and control fibroblasts. J Cell Physiol. 2019 Aug;234(10):18344-18348.
搜索质检报告(COA)
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[2]. Anna Petroni, et al. Thermogenic flux induced by lignoceric acid in peroxisomes isolated from HepG2 cells and from X-adrenoleukodystrophy and control fibroblasts. J Cell Physiol. 2019 Aug;234(10):18344-18348.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2